These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


242 related items for PubMed ID: 21364341

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Flupenthixol-induced tardive dystonia presenting as severe dysphagia.
    Agarwal PA, Ichaporia NR.
    Neurol India; 2010; 58(5):784-5. PubMed ID: 21045513
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Botulinum toxin in the treatment of lingual movement disorders.
    Kasravi N, Jog MS.
    Mov Disord; 2009 Nov 15; 24(15):2199-202. PubMed ID: 19795478
    [Abstract] [Full Text] [Related]

  • 5. Tardive dyskinesia: clinical presentation and treatment.
    van Harten PN, Tenback DE.
    Int Rev Neurobiol; 2011 Nov 15; 98():187-210. PubMed ID: 21907088
    [Abstract] [Full Text] [Related]

  • 6. [The use of botulinum toxin in otorhinolaryngology--experiences and outlook].
    Laskawi R.
    Laryngorhinootologie; 1997 Nov 15; 76(11):656-9. PubMed ID: 9517972
    [No Abstract] [Full Text] [Related]

  • 7. Botulinum toxin in painful tardive dyskinesia.
    Tschopp L, Salazar Z, Micheli F.
    Clin Neuropharmacol; 2009 Nov 15; 32(3):165-6. PubMed ID: 19483486
    [Abstract] [Full Text] [Related]

  • 8. [Botulinum toxin therapy: from dreaded biological toxin to standard pharmaceutical].
    Schnider P, Voller B, Moraru K, Auff E.
    Wien Klin Wochenschr; 1999 Oct 29; 111(20):825-9. PubMed ID: 10586486
    [No Abstract] [Full Text] [Related]

  • 9. Botulinum toxin as a treatment for tardive dyskinesia.
    van Harten PN, Hovestadt A.
    Mov Disord; 2006 Aug 29; 21(8):1276-7. PubMed ID: 16671083
    [Abstract] [Full Text] [Related]

  • 10. Botulinum toxin in movement disorders.
    Papapetropoulos S, Singer C.
    Semin Neurol; 2007 Apr 29; 27(2):183-94. PubMed ID: 17390263
    [Abstract] [Full Text] [Related]

  • 11. Risperidone-induced tardive dyskinesia.
    Bassitt DP, de Souza Lobo Garcia L.
    Pharmacopsychiatry; 2000 Jul 29; 33(4):155-6. PubMed ID: 10958268
    [No Abstract] [Full Text] [Related]

  • 12. [Botulinum toxin in neurology].
    Vidailhet M.
    Rev Med Interne; 2005 Jul 29; 26(7):531-3. PubMed ID: 15975692
    [No Abstract] [Full Text] [Related]

  • 13. [Torticollis spasmodicus as a manifestation of tardive dystonia].
    Silberbauer C, Rittmannsberger H.
    Fortschr Neurol Psychiatr; 1995 Oct 29; 63(10):388-92. PubMed ID: 8529987
    [Abstract] [Full Text] [Related]

  • 14. Tardive and idiopathic oromandibular dystonia: a clinical comparison.
    Tan EK, Jankovic J.
    J Neurol Neurosurg Psychiatry; 2000 Feb 29; 68(2):186-90. PubMed ID: 10644785
    [Abstract] [Full Text] [Related]

  • 15. Guidelines for the therapeutic use of botulinum toxin in movement disorders.
    Pagni CA.
    Ital J Neurol Sci; 1998 Jun 29; 19(3):189-90. PubMed ID: 10933476
    [No Abstract] [Full Text] [Related]

  • 16. Botulinum toxin: clinical use.
    Truong DD, Jost WH.
    Parkinsonism Relat Disord; 2006 Sep 29; 12(6):331-55. PubMed ID: 16870487
    [Abstract] [Full Text] [Related]

  • 17. Treatment of clozapine-associated tardive dyskinesia.
    Lin CC, Bai YM, Chen JY, Wang YC, Liou YJ.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb 15; 32(2):599-600. PubMed ID: 17920744
    [No Abstract] [Full Text] [Related]

  • 18. [Hemifacial spasm and its treatment with botulinum toxin].
    Gouider-Khouja N, Turki I, Ben Hamida M, Hentati F.
    Tunis Med; 1999 Jan 15; 77(1):41-4. PubMed ID: 10333697
    [No Abstract] [Full Text] [Related]

  • 19. Botulinum toxin in the treatment of orofacial tardive dyskinesia: a single blind study.
    Slotema CW, van Harten PN, Bruggeman R, Hoek HW.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb 15; 32(2):507-9. PubMed ID: 18022743
    [Abstract] [Full Text] [Related]

  • 20. The use of botulinum toxin in the treatment of refractory overactive bladder.
    Mucksavage P, Smith AL, Moy ML.
    Ostomy Wound Manage; 2006 Dec 15; 52(12):28, 30, 32-3. PubMed ID: 17219700
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.